市場調査レポート

商品コード

1619310

呼吸器疾患検査市場規模、シェア、成長分析、検査タイプ別、用途別、地域別 - 産業別予測、2024～2031年

Respiratory Disease Testing Market Size, Share, Growth Analysis, By Test Type (Mechanical Tests, Imaging Tests), By Application (Lung Cancer, Asthma), By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

呼吸器疾患検査の世界市場規模は2022年に61億7,000万米ドルと評価され、2023年の63億4,000万米ドルから2031年には78億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは2.7％で成長する見通しです。

世界の呼吸器疾患検査市場は、喘息、COPD、肺がんなどの呼吸器疾患の有病率が上昇し、公害、喫煙、高齢化によって悪化していることを背景に、力強い成長を遂げています。分子診断、免疫測定、画像診断の技術的進歩に支えられ、検査効率と検査結果が向上し、正確な診断方法に対する緊急性が高まっています。COVID-19の大流行は呼吸器検査の重要性をさらに浮き彫りにし、PCRや抗原検査を含む多様な検査法に対する需要を牽引しました。しかし、低所得地域でのアクセスを制限する高い検査費用、認識不足、特に発展途上地域における不十分なインフラなどの課題も残されています。さらに、規制上のハードルが技術革新や製品発売の妨げになる可能性があり、患者ケアにおける検査の重要な役割に対する理解を深めるための教育的イニシアチブの必要性が強調されています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Beckton Dickinson and Company
Koninklijke Philips N.V.
ResMed Inc.
Medtronic
MG Diagnostic Corporation
Abbott
ThermoFisher Scientific
Biomerieux
QIAGEN
Seimens Healthineers AG
F. Hoffmann-La Roche Ltd
SDI Diagnostics
BD
Niterra Co., Ltd.
QuantuMDx Group Ltd.
COSMED srl
Bird Healthcare
visby medical
Seegene Inc
Bio-Rad Laboratories Inc

結論と推奨事項

Product Code: SQMIG35A2825

Global Respiratory Disease Testing Market size was valued at USD 6.17 billion in 2022 and is poised to grow from USD 6.34 billion in 2023 to USD 7.84 billion by 2031, growing at a CAGR of 2.7% during the forecast period (2024-2031).

The global respiratory disease testing market has witnessed robust growth, fueled by the rising prevalence of respiratory conditions like asthma, COPD, and lung cancer, exacerbated by pollution, smoking, and aging populations. The urgency for accurate diagnostic methods has escalated, supported by technological advancements in molecular diagnostics, immunoassays, and imaging, which enhance testing efficiency and outcomes. The COVID-19 pandemic further underscored the importance of respiratory testing, driving demand for diverse testing methods, including PCR and antigen tests. However, challenges remain, including high testing costs limiting access in low-income areas, awareness deficits, and inadequate infrastructure, particularly in developing regions. Additionally, regulatory hurdles may impede innovation and product launches, emphasizing the need for educational initiatives to enhance understanding of testing's critical role in patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Respiratory Disease Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Respiratory Disease Testing Market Segmental Analysis

Global Respiratory Disease Testing Market is segmented by test type, application, end-use and region. Based on test type, the market is segmented into mechanical tests, imaging tests and in-vitro diagnostic tests. Based on application, the market is segmented into chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis and other. Based on end-use, the market is segmented into hospital, physicians clinic and clinical laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Respiratory Disease Testing Market

The global respiratory disease testing market is primarily driven by the escalating incidence of respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Contributing factors such as environmental pollution, tobacco use, and an aging population are exacerbating the prevalence of these diseases worldwide. This surge in respiratory health issues underscores the urgent necessity for reliable and effective testing solutions, prompting healthcare providers and patients alike to seek out advanced diagnostic tools. As the demand for precise testing continues to rise, the respiratory disease testing market is expected to experience significant growth in response to these pressing public health challenges.

Restraints in the Global Respiratory Disease Testing Market

The Global Respiratory Disease Testing market faces significant restraints due to rigorous regulatory approval processes. The complexity involved in navigating these regulations can create substantial hurdles for market participants. Securing the necessary approvals for new testing technologies often requires extensive time and financial resources, resulting in prolonged delays for product launches. This situation not only stifles innovation but also restricts the ability of companies to introduce cutting-edge solutions to the market. Consequently, the challenging regulatory landscape may inhibit the overall growth and advancement of the respiratory disease testing sector, limiting potential improvements in patient care and disease management.

Market Trends of the Global Respiratory Disease Testing Market

The Global Respiratory Disease Testing market is witnessing a notable trend towards increased emphasis on point-of-care testing (POCT), which facilitates swift diagnosis and immediate treatment decisions directly at the patient's location. This surge in demand is largely fueled by the need for rapid and precise results, particularly within critical care environments and resource-constrained areas, where traditional laboratory testing may be less feasible. As healthcare providers prioritize quick turnaround times to enhance patient outcomes, the adoption of innovative point-of-care testing devices and platforms is expected to rise significantly, marking a transformative shift in respiratory disease management and testing approaches globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Respiratory Disease Testing Market Size by Test Type & CAGR (2024-2031)

Market Overview
Mechanical Tests
- Spirometry
- Peak-Flow Test
- Pulmonary Function Test
- Blood Gas Test
- Others
Imaging Tests
- X-Ray
- Ct-Scan
- Ultrasonography
- Mri
In-Vitro Diagnostic Tests
- Point-Of-Care Test
- Molecular Diagnostic Test

Global Respiratory Disease Testing Market Size by Application & CAGR (2024-2031)

Market Overview
Chronic Obstructive Pulmonary Disease
Lung Cancer
Asthma
Tuberculosis
Other

Global Respiratory Disease Testing Market Size by End-Use & CAGR (2024-2031)

Market Overview
Hospital
Physicians Clinic
Clinical Laboratories

Global Respiratory Disease Testing Market Size & CAGR (2024-2031)

North America (Test Type, Application, End-Use)
- USA
- Canada
Europe (Test Type, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Beckton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MG Diagnostic Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThermoFisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seimens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SDI Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Niterra Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuantuMDx Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COSMED srl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bird Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
visby medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

呼吸器疾患検査市場規模、シェア、成長分析、検査タイプ別、用途別、地域別 - 産業別予測、2024～2031年

Respiratory Disease Testing Market Size, Share, Growth Analysis, By Test Type (Mechanical Tests, Imaging Tests), By Application (Lung Cancer, Asthma), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

呼吸器疾患検査市場規模：検査タイプ別

呼吸器疾患検査市場規模：用途別

呼吸器疾患検査市場規模：最終用途別

呼吸器疾患検査市場規模：地域別